Posted by Michael Wonder on 23 Mar 2023
Drug makers push back on a clever tactic employers use to avoid paying for specialty medicines
22 March 2023 - In the face of rising drug prices, health plan sponsors have quietly used a clever, but questionable tactic over the past few years to deflect costs. And now, some pharmaceutical companies are pushing back.
The manoeuvre goes by different names — it’s sometimes called a specialty carve out, or alternative funding – but relies on exploiting charitable programs.
